Your browser doesn't support javascript.
loading
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer.
Hu-Lieskovan, Siwen; Lisberg, Aaron; Zaretsky, Jesse M; Grogan, Tristan R; Rizvi, Hira; Wells, Daniel K; Carroll, James; Cummings, Amy; Madrigal, John; Jones, Benjamin; Gukasyan, Jacklin; Shintaku, I Peter; Slamon, Dennis; Dubinett, Steven; Goldman, Jonathan W; Elashoff, David; Hellmann, Matthew D; Ribas, Antoni; Garon, Edward B.
Afiliação
  • Hu-Lieskovan S; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Lisberg A; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Zaretsky JM; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Grogan TR; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Rizvi H; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Wells DK; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Carroll J; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Cummings A; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Madrigal J; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Jones B; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Gukasyan J; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Shintaku IP; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Slamon D; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Dubinett S; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Goldman JW; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Elashoff D; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Hellmann MD; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
  • Ribas A; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Garon EB; Weill Cornell Medical College, New York, New York.
Clin Cancer Res ; 25(16): 5061-5068, 2019 08 15.
Article em En | MEDLINE | ID: mdl-31113840
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos